Dr. Mezgebe Berhe, MD

Dr. Berhe practices at Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health.

Dr. Berhe's NPI, 1831155787, was assigned on April 20, 2006. Dr. Berhe graduated from Addis Ababa University Faculty of Medicine in 1993. Dr. Berhe holds Texas license M1510.

Dr. Berhe's primary practice is Baylor University Medical Center, at 3500 Gaston Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-8082.

Dr. Berhe's primary practice is Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health. Dr. Berhe is also affiliated with Baylor Scott & White The Heart Hospital - Dallas. The medical group on file is North Texas Infectious Diseases Consultants. Dmand AI also links Dr. Berhe to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berhe practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Berhe's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Berhe is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Berhe's licenses on file in 2 states: Texas and Virginia.

Dmand AI lists acute skin infection, cold sores or genital herpes, gastrointestinal infection, hiv/aids, immune deficiency disease, joint or bone infection, pneumonia and UTI among the conditions Dr. Berhe treats.

CMS data shows 66,507 Medicare services from Dr. Berhe across 22 procedure codes in 2024, for 709 Medicare patients. Medicare paid $784,811 for them.

CMS counts 709 Medicare patients who saw Dr. Berhe in 2024. The largest group is 65 to 74, with 287 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berhe's median patient age at 64, with 44% women.

In 2024, Dr. Berhe wrote 1,816 Medicare Part D claims for 285 patients. 69% of them were for generic drugs. CMS names the drug for 1,540 of them, across 42 drugs with 11 or more claims each, at $2,124,706 in total drug cost. In 2023, CMS named 1,796 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Berhe for performance year 2024, reported as part of a group. Dr. Berhe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berhe as offering telehealth.

Dmand AI links 13 papers to Dr. Berhe, published from 2018 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Guideline Adherence and Infection Control. Dr. Berhe has published most often in Proc (Bayl Univ Med Cent). Dr. Berhe's most frequent co-authors are Uriel Sebastian Sandkovsky, MD, MS, Tony Alias, MD and Kevin D. Cannon, MD.

CMS Open Payments shows 869 general payments to Dr. Berhe from 39 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. ViiV Healthcare Company paid the most, $35,170. It also lists 19 research payments totaling $4,914 from 2016 to 2022.

Dr. Berhe graduated from Addis Ababa University Faculty of Medicine in 1993.

Dr. Berhe is in network with 23 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.